Physician profile
Sheldon S Lin
NPI 1952475022
$6,958.02
in general payments reported to CMS, 2019-2025
14 companies · $91.15 in 2025
The $91.15 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,727 · 2020: $252 · 2021: $2,531 · 2022: $785 · 2023: $428 · 2024: $144 · 2025: $91.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $4,566.60 | 2019-2021 | |
| Novastep INC. | $932.14 | 2021-2023 | Apollo Ankle Fracture Plating System, Pecaplasty |
| Stryker Corporation | $373.27 | 2022-2024 | Infinity Adaptis, Inbone, Viaflow |
| Royal Biologics, INC. | $252.27 | 2020 | |
| Wright Medical Technology, INC. | $206.33 | 2019 | |
| Zimmer Biomet Holdings, INC. | $157.61 | 2021-2022 | |
| Medtronic USA, INC. | $136.16 | 2019 | |
| Fusion Orthopedics USA, LLC | $91.15 | 2025 | |
| Paragon 28, INC. | $83.60 | 2022-2023 | Portfolio |
| Djo, LLC | $59.34 | 2019 | |
| Tenex Health INC. | $43.82 | 2021 | |
| Integra Lifesciences Corporation | $37.79 | 2019 | |
| Depuy Synthes Sales INC. | $17.94 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.